ReviewFrontiers in chemistry2026
Linking molecular architecture to antibacterial functions: a chemical biology view of cyclic depsipeptides.
Review in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial depsipeptides and cyclodepsipeptides represent a structurally diverse class of natural products that have gained renewed attention as both antibacterial agents and molecular tools to interrogate bacterial physiology. Characterized by the incorporation of ester linkages within macrocyclic peptide frameworks, these molecules exhibit unique conformational properties that underpin distinct modes of action including lipid II recognition, membrane perturbation, and enzyme modulation. This review summarizes advances in discovery, chemical synthesis, and structure activity relationship studies across major depsipeptide families, highlighting how precise chemical features such as macrocycle topology, stereochemical configuration, hydroxylation patterns, and lipidation dictate biological function. By integrating mechanistic insights from chemical biology, microbiology, and medicinal chemistry, we illustrate how cyclodepsipeptides serve as privileged scaffolds for probing bacterial cell envelope organization and essential biosynthetic pathways. In the context of escalating antimicrobial resistance and limited innovation in small molecule antibiotics, these macrocyclic peptides offer valuable opportunities for mechanism driven probe development and therapeutic translation. Collectively, this article provides a unified framework linking molecular structure to antibacterial activity and aims to guide the rational design of next-generation peptide-based antibiotics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.